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Tumor invasion defines the transition between tissue-restricted carcinomas, with 
good outcome as optimal surgery becomes possible, and metastatic tumors associated 
with poor prognosis and a dramatic decreased in survival. In endometrial cancer, 
myometrial infiltration represents a determinant parameter highly valuable in prognosis. 
A profound spatio-temporal regulation from both the tumor and the surrounding stroma 
occurs at the invasive front. To date, the identification of proteins involved in endometrial 
carcinoma invasion has been essentially conducted by immunohistochemical methods, 
without a global perception on the invasive front.
In this work we attempted a proteomic approach to characterise specific components 
of the invasive front or reactive stroma by comparing, using 2D-DIGE, the invasive area 
of an endometrial carcinoma with the non-invasive superficial area and normal tissue 
from the same patients. This strategy led us to identify proteins involved in cellular 
morphology, assembly and movement, differentially expressed at the invasive front, as 
well as pathways like cell-to-cell signalling and interaction or a modulated response to 
oxidative stress as events related to endometrial carcinoma invasion.
In conclusion, we describe a novel proteomic approach that specifically tackles with 
endometrial carcinoma invasion front, allowing the identification of new players of 
myometrial infiltration.
